SCHEMBL2190229

SCHEMBL2190229

C[S+]([O-])CCc1cc(NC(=O)C(F)(F)F)ccc1S(=O)(=O)Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
EPHX2 P34913 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 1/20 0.38
MTNR1B P49286 1/20 0.38
CNR2 P34972 1/20 0.38
ABCC9 O60706 2/20 0.37
ABCC8 Q09428 2/20 0.37
KCNJ11 Q14654 2/20 0.37
KCNJ8 Q15842 2/20 0.37
POLB P06746 1/20 0.37
NPY5R Q15761 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1820493 0.84 CA12 (0.43) CYP1A2CYP2C9CYP2C19CA12CA1
SCHEMBL1819384 0.83 L3MBTL1 (0.44) CYP1A2CYP2C9CYP2C19CA12CA1
SCHEMBL15006369 0.83 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19CA12CA1
SCHEMBL1817450 0.82 MTNR1B (0.47) CYP1A2CYP2C9CYP2C19CA12CA1
SCHEMBL1815977 0.81 CA12 (0.46) CYP1A2CYP2C9CYP2C19CA12CA1
SCHEMBL1816821 0.81 CYP1A2 (0.48) CYP1A2CYP2C9CYP2C19CA12CA1
SCHEMBL1817181 0.81 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19CA12CA1
SCHEMBL1816870 0.81 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19CA12CA1
SCHEMBL1818821 0.78 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19CA12CA1
SCHEMBL1819456 0.77 CYP2C9 (0.40) CYP1A2CYP2C9CYP2C19CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461134-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2013-06-11 US disclosed
US-20110172187-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172187-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, BCL6, BTD CYP1A2 3504/4885CYP2C9 3001/4885CYP2C19 3226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.